Valuation : PharmaEssentia Corporation

Market Cap 530B 16.77B 14.45B 13.68B 12.4B 23.27B 1,602B 23.39B 163B 62.49B 815B 62.99B 61.61B 2,576B P/E 2026 *
48.3x
P/E 2027 * 30.4x
Enterprise Value 504B 15.93B 13.73B 13B 11.78B 22.1B 1,522B 22.22B 154B 59.37B 774B 59.84B 58.53B 2,447B EV / Sales 2026 *
17.8x
EV / Sales 2027 * 12.4x
Free-Float
77.98%
Yield 2026 *
0.31%
Yield 2027 * 0.18%
1 day-3.03%
1 week-2.29%
Current month-8.24%
1 month-12.33%
3 months+52.02%
6 months+111.92%
Current year+202.10%
1 week 1,280
Extreme 1280
1,450
1 month 1,280
Extreme 1280
1,645
Current year 423.7
Extreme 423.699083
1,645
1 year 407.92
Extreme 407.923053
1,645
3 years 228.27
Extreme 228.269713
1,645
5 years 56.05
Extreme 56.051993
1,645
10 years 43.54
Extreme 43.541837
1,645
Manager TitleAgeSince
Chief Executive Officer - 31/12/2016
Director of Finance/CFO - 13/10/2015
President - 24/06/2015
Director TitleAgeSince
Director/Board Member - 08/05/2000
Chairman - 23/09/2012
Director/Board Member - 28/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
-3.03%-2.29%+185.12%+334.07% 16.77B
-2.11%-1.68%+44.52%+95.15% 66.93B
-0.23%-4.45%+30.39%+73.64% 61.97B
+1.67%+2.47%-11.23%+388.34% 28.27B
-1.05%-4.43%+30.56%+10.07% 24.59B
+0.34%-6.78%-7.27%-17.99% 24.3B
+0.43%-3.37%+14.85%-19.29% 19.41B
-1.94%-4.94%-5.29%+495.65% 14.18B
-2.28%-4.90%+43.64%+155.21% 13.91B
+3.24%-0.31%-5.65%+976.69% 14.01B
Average -0.50%-3.14%+31.96%+249.15% 28.43B
Weighted average by Cap. -0.64%-2.93%+31.53%+175.21%

Financials

2026 *2027 *
Net sales 28.33B 896M 772M 731M 662M 1.24B 85.57B 1.25B 8.68B 3.34B 43.53B 3.36B 3.29B 138B 40.06B 1.27B 1.09B 1.03B 937M 1.76B 121B 1.77B 12.27B 4.72B 61.56B 4.76B 4.65B 195B
Net income 11.02B 348M 300M 284M 258M 483M 33.29B 486M 3.38B 1.3B 16.94B 1.31B 1.28B 53.52B 17.69B 559M 482M 456M 414M 776M 53.44B 780M 5.42B 2.08B 27.19B 2.1B 2.05B 85.9B
Net Debt -26.52B -839M -723M -684M -620M -1.16B -80.12B -1.17B -8.13B -3.12B -40.76B -3.15B -3.08B -129B -34.73B -1.1B -946M -896M -812M -1.52B -105B -1.53B -10.64B -4.09B -53.37B -4.12B -4.03B -169B
Logo PharmaEssentia Corporation
PHARMAESSENTIA CORPORATION is a Taiwan-based company primarily engaged in the research and development, clinical trials, manufacturing, sale, and marketing of innovative biotechnology drugs. It also oversees registration and marketing authorization applications based on product development progress. The Company focuses on hematology and oncology, utilizing the PEGylation technology platform for drug candidate design and development. The Company’s proprietary product, Ropeg, is used to treat polycythemia vera (PV), primarily sold in the United States.
Employees
131
Date Price Change Volume
11/09/26 NT$1,280.00 -3.03% 2,676,454
10/09/26 NT$1,320.00 -1.86% 2,750,274
09/09/26 NT$1,345.00 -4.27% 4,564,007
08/09/26 NT$1,405.00 +6.04% 4,860,872
07/09/26 NT$1,325.00 +1.15% 4,821,947
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,280.00TWD
Average target price
1,397.26TWD
Spread / Average Target
+9.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!